share_log

HC Wainwright & Co. Maintains Buy on Affimed, Raises Price Target to $10

HC Wainwright & Co. Maintains Buy on Affimed, Raises Price Target to $10

HC Wainwright & Co.在Affimed上維持買入,將目標股價上調至10美元
Moomoo 24/7 ·  04/01 06:36

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Affimed (NASDAQ:AFMD) with a Buy and raises the price target from $5 to $10.

HC Wainwright & Co. 分析師Swayampakula Ramakanth維持Afimed(納斯達克股票代碼:AFMD)的買入並將目標股價從5美元上調至10美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論